Atlas Venture Life Science Advisors as of March 31, 2024
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dyne Therapeutics Common Stock (DYN) | 21.0 | $228M | 8.0M | 28.39 | |
| Kymera Therapeutics Common Stock (KYMR) | 19.9 | $216M | 5.4M | 40.20 | |
| Disc Medicine Common Stock (IRON) | 13.1 | $142M | 2.3M | 62.26 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 9.8 | $106M | 6.4M | 16.52 | |
| Third Harmonic Bio Common Stock (THRD) | 9.5 | $103M | 11M | 9.44 | |
| Korro Bio Common Stock (KRRO) | 9.3 | $101M | 1.1M | 90.00 | |
| Aerovate Therapeutics Common Stock (AVTE) | 5.6 | $60M | 2.0M | 29.57 | |
| Q32 Bio Common Stock | 3.3 | $36M | 2.1M | 17.04 | |
| Generation Bio Common Stock (GBIO) | 3.1 | $34M | 8.3M | 4.07 | |
| Vigil Neuroscience Common Stock (VIGL) | 1.8 | $20M | 5.8M | 3.41 | |
| Replimune Group Common Stock (REPL) | 1.6 | $17M | 2.1M | 8.17 | |
| Ikena Oncology Common Stock (IKNA) | 0.7 | $7.1M | 5.0M | 1.42 | |
| AvroBio Common Stock (AVRO) | 0.5 | $5.8M | 4.5M | 1.28 | |
| Dianthus Therapeutics Common Stock (DNTH) | 0.5 | $5.6M | 187k | 30.00 | |
| Xilio Therapeutics Common Stock (XLO) | 0.1 | $1.1M | 993k | 1.08 | |
| Spero Therapeutics Common Stock (SPRO) | 0.1 | $1.0M | 608k | 1.72 |
